Post Holdings Q3 2026: A Delicate Rebalance of Sales, Margin and the EBITDA Compass

Executive snapshot

POST’s quarter reflects a mix shift and the aftermath of strategic portfolio moves. The quarter’s net sales declined 1.8% versus the prior year, partly due to the lapping effects of prior-year pricing in select segments and the absence/presence of acquisitions and divestitures in the current period. Yet gross profit held at 29.1% of net sales (566.3 million), a 5% margin contraction versus a year ago. The operating profit came in at 189.3 million, and net earnings were 63.4 million—down meaningfully from the prior year, with diluted EPS of 1.29 versus 1.79 a year earlier. The company also flags a non-GAAP path: Adjusted net earnings of 91.1 million and Adjusted EBITDA of 377.3 million, down modestly versus last year.

In a quick triage: Weetabix sales were flat; the period features ongoing portfolio actions, including the Crystal Farms Dairy disposition and the 8th Avenue acquisition activity, which shape the year-to-date base and the implied future margin structure.

Quarterly highlights

• Net sales (Q3): 1,948.0 million, down 1.8% year over year; current year includes 8th Avenue contributions totaling 141.8 million in net sales.
• Gross profit: 566.3 million (29.1% of net sales), down 5.0% year over year.
• SG&A: 326.1 million, or 16.7% of net sales, up 4.5% versus the prior year.
• Operating profit: 189.3 million, down 19.3% year over year.
• Net earnings: 63.4 million; Diluted EPS 1.29 per share (vs. 1.79 in the prior year).
• Non-GAAP metrics: Adjusted net earnings 91.1 million; Adjusted diluted EPS 1.78; Adjusted EBITDA 377.3 million (down 5.0% vs. prior year).

Nine-month performance: momentum with a caveat

For the first nine months, POST reports net sales of 6,165.5 million, an increase of 254.4 million from the prior year. Gross profit for the period rose to 1,822.4 million, or 29.6% of net sales, up 4.9% in absolute terms. SG&A rose to 1,009.6 million (16.4% of net sales), while operating profit edged up to 639.6 million, a 1.4% improvement year over year. Net earnings were 242.1 million, down 15.0% from the prior year. The result underscores a portfolio mix where margin discipline and volume shifts matter as much as headline net sales growth.

The release notes that the nine-month numbers include a number of portfolio actions and segment contributions, with detailed figures for each line item (including adjustments) typically summarized in accompanying disclosures and tables. The emphasis remains on Adjusted EBITDA and non-GAAP measures as the lens through which executives guide expectations for the coming year.

Outlook and disclosures

Guidance centers on Adjusted EBITDA rather than a traditional revenue forecast. The company narrowed its fiscal 2026 Adjusted EBITDA outlook to a range of 1,560–1,570 million and provided an exploratory outlook for fiscal 2027 that hinges on portfolio performance, cost discipline, and the timing of any further inorganic moves. The non-GAAP framing is explicit: Post provides Adjusted EBITDA guidance on a non-GAAP basis and does not provide a reconciliation to GAAP for forward-looking figures due to forecasting challenges around certain adjustments. In practical terms, investors are being asked to evaluate the EBITDA exit rate and the quality of earnings—especially given the sale of Crystal Farms and the 8th Avenue activity—and to watch how the Weetabix franchise and other anchors contribute to margins over the next year.

Strategic context: what this might portend for POST and peers

The quarterly narrative is increasingly about portfolio optics and the efficiency of the operating model, not just the top-line delta. The Crystal Farms disposition and the 8th Avenue acquisition have altered the segment mix, which can compress or lift gross margins depending on product mix and pricing dynamics. The flat Weetabix performance provides a reminder that even well-known brands struggle to defy macro pressures in food-on-the-go and value-oriented channels.

For sector peers, the message is twofold: first, non-GAAP metrics like Adjusted EBITDA remain central to how companies communicate profitability and cash generation to the market; second, disciplined capital allocation—combining asset dispositions with selective acquisitions—can stabilize margins even when reported GAAP net earnings wobble. Analysts will want to see how the outlook for 2027 evolves as portfolio changes crystallize and as input costs, pricing leverage, and mix effects play out across meals and snacks.

Bottom line

POST’s Q3 narrative is less about a dramatic earnings surprise and more about a careful orchestration of assets and operating leverage. The EPS figure tells part of the story, but the more informative notes lie in Adjusted EBITDA trajectories, the nine-month margin story, and the outlook that hinges on portfolio evolution. For investors who track revenue forecasts in their models and parse EPS consensus versus reported figures, this release provides a clear signal: the path to a more durable earnings profile sits in portfolio optimization and disciplined cost management, with EBITDA as the compass.